409 related articles for article (PubMed ID: 34774086)
21. Evaluation of a COVID-19 Vaccine Campaign and SARS-CoV-2 Infection and Mortality Among Adults Aged 60 Years And Older in a Middle-Income Country.
Macchia A; Ferrante D; Angeleri P; Biscayart C; Mariani J; Esteban S; Tablado MR; de Quirós FGB
JAMA Netw Open; 2021 Oct; 4(10):e2130800. PubMed ID: 34714342
[TBL] [Abstract][Full Text] [Related]
22. Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity - Nine States, January-September 2021.
Bozio CH; Grannis SJ; Naleway AL; Ong TC; Butterfield KA; DeSilva MB; Natarajan K; Yang DH; Rao S; Klein NP; Irving SA; Dixon BE; Dascomb K; Liao IC; Reynolds S; McEvoy C; Han J; Reese SE; Lewis N; Fadel WF; Grisel N; Murthy K; Ferdinands J; Kharbanda AB; Mitchell PK; Goddard K; Embi PJ; Arndorfer J; Raiyani C; Patel P; Rowley EA; Fireman B; Valvi NR; Griggs EP; Levy ME; Zerbo O; Porter RM; Birch RJ; Blanton L; Ball SW; Steffens A; Olson N; Williams J; Dickerson M; McMorrow M; Schrag SJ; Verani JR; Fry AM; Azziz-Baumgartner E; Barron M; Gaglani M; Thompson MG; Stenehjem E
MMWR Morb Mortal Wkly Rep; 2021 Nov; 70(44):1539-1544. PubMed ID: 34735425
[TBL] [Abstract][Full Text] [Related]
23. Survival and risk of COVID-19 after SARS-COV-2 vaccination in a series of 2391 cancer patients.
Heudel P; Favier B; Solodky ML; Assaad S; Chaumard N; Tredan O; Bachelot T; Ray-Coquard I; Russias B; Fournier ML; Mastroianni B; Avrillon V; Michallet AS; Zrounba P; Chabaud S; Perol D; Blay JY
Eur J Cancer; 2022 Apr; 165():174-183. PubMed ID: 35245864
[TBL] [Abstract][Full Text] [Related]
24. COVID-19 vaccines and cancer patients: acceptance, attitudes and safety.
Matovina Brko G; Popovic M; Jovic M; Radic J; Bodlovic Kladar M; Nikolic I; Vidovic V; Kolarov Bjelobrk I; Kukic B; Salma S; Litavski J; Petrovic N; Vranjkovic B; Roganovic T; Ruzic M; Dugandzija T; Popovic L
J BUON; 2021; 26(5):2183-2190. PubMed ID: 34761633
[TBL] [Abstract][Full Text] [Related]
25. Subacute thyroiditis during the COVID-19 pandemic: a prospective study.
Bahçecioğlu AB; Karahan ZC; Aydoğan BI; Kalkan IA; Azap A; Erdoğan MF
J Endocrinol Invest; 2022 Apr; 45(4):865-874. PubMed ID: 35023078
[TBL] [Abstract][Full Text] [Related]
26. Features of the humoral response to immunization "Gam-COVID-Vac" and in patients with COVID-19.
Akinshina YA; Mardanly SG; Rotanov SV; Pomazanov VV; Kiseleva VA; Ermolaev III
Klin Lab Diagn; 2022 Apr; 67(4):227-233. PubMed ID: 35575396
[TBL] [Abstract][Full Text] [Related]
27. Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution.
Pimpinelli F; Marchesi F; Piaggio G; Giannarelli D; Papa E; Falcucci P; Pontone M; Di Martino S; Laquintana V; La Malfa A; Di Domenico EG; Di Bella O; Falzone G; Ensoli F; Vujovic B; Morrone A; Ciliberto G; Mengarelli A
J Hematol Oncol; 2021 May; 14(1):81. PubMed ID: 34001183
[TBL] [Abstract][Full Text] [Related]
28. Counseling in maternal-fetal medicine: SARS-CoV-2 infection in pregnancy.
Di Mascio D; Buca D; Berghella V; Khalil A; Rizzo G; Odibo A; Saccone G; Galindo A; Liberati M; D'Antonio F
Ultrasound Obstet Gynecol; 2021 May; 57(5):687-697. PubMed ID: 33724545
[TBL] [Abstract][Full Text] [Related]
29. High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR.
Assaad S; Avrillon V; Fournier ML; Mastroianni B; Russias B; Swalduz A; Cassier P; Eberst L; Steineur MP; Kazes M; Perol M; Michallet AS; Rey P; Erena-Penet AS; Morel A; Brahmi M; Dufresne A; Tredan O; Chvetzoff G; Fayette J; de la Fouchardiere C; Ray-Coquard I; Bachelot T; Saintigny P; Tabutin M; Dupré A; Nicolas-Virelizier E; Belhabri A; Roux PE; Fuhrmann C; Pilleul F; Basle A; Bouhamama A; Galvez C; Herr AL; Gautier J; Chabaud S; Zrounba P; Perol D; Blay JY
Eur J Cancer; 2020 Aug; 135():251-259. PubMed ID: 32540204
[TBL] [Abstract][Full Text] [Related]
30. Immune checkpoint blocking impact and nomogram prediction of COVID-19 inactivated vaccine seroconversion in patients with cancer: a propensity-score matched analysis.
Ma Y; Liu N; Wang Y; Zeng J; Hu YY; Hao W; Shi H; Zhu P; Lv J; Fan W; Wang X
J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34845005
[TBL] [Abstract][Full Text] [Related]
31. Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy.
Wang Y; Yang C; Song Y; Coleman JR; Stawowczyk M; Tafrova J; Tasker S; Boltz D; Baker R; Garcia L; Seale O; Kushnir A; Wimmer E; Mueller S
Proc Natl Acad Sci U S A; 2021 Jul; 118(29):. PubMed ID: 34193524
[TBL] [Abstract][Full Text] [Related]
32. Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials.
Xia S; Duan K; Zhang Y; Zhao D; Zhang H; Xie Z; Li X; Peng C; Zhang Y; Zhang W; Yang Y; Chen W; Gao X; You W; Wang X; Wang Z; Shi Z; Wang Y; Yang X; Zhang L; Huang L; Wang Q; Lu J; Yang Y; Guo J; Zhou W; Wan X; Wu C; Wang W; Huang S; Du J; Meng Z; Pan A; Yuan Z; Shen S; Guo W; Yang X
JAMA; 2020 Sep; 324(10):951-960. PubMed ID: 32789505
[TBL] [Abstract][Full Text] [Related]
33. Acute relapse and poor immunization following COVID-19 vaccination in a rituximab-treated multiple sclerosis patient.
Etemadifar M; Sigari AA; Sedaghat N; Salari M; Nouri H
Hum Vaccin Immunother; 2021 Oct; 17(10):3481-3483. PubMed ID: 34015240
[TBL] [Abstract][Full Text] [Related]
34. Frequency and Characteristics of Nodal and Deltoid FDG and
Schroeder DG; Jang S; Johnson DR; Takahashi H; Navin PJ; Broski SM; Thorpe MP; Johnson GB; Young JR
AJR Am J Roentgenol; 2021 Nov; 217(5):1206-1216. PubMed ID: 34009000
[No Abstract] [Full Text] [Related]
35. COVID-19 in cancer patients: patient characteristics and outcomes in the post-COVID-19 vaccination period.
Iskender G; Mert D; Yapar Toros G; Yilmaz F; Bozan E; Tunçbilek S; Çakmak Öksüzoğlu ÖB; Altuntaş F; Ertek M
Turk J Med Sci; 2023; 53(6):1744-1755. PubMed ID: 38813483
[TBL] [Abstract][Full Text] [Related]
36. COVID-19 vaccines breakthrough infection and adverse reactions in medical students: a nationwide survey in Iran.
Allahgholipour A; Safavi-Naini SAA; Shekarriz Foomany Z; Eskandari A; Nazari Rostami H; Honarvar MJ; Mohammadi M; Khalili P; Ilaghi M; Afshar H; Amini Baghbadorani A; Moghimi HR; Chamani Goorabi A; Mehrparvar A; Safari M; Nakhli AS; Mahmoudabadi M; Seifadini A; Sheikhansari S; Khojastehfar S; Mahdavi P; Mohammadi M; Ashrafi Barzideh S; Akbarzadeh N; Delavarpour Moghadam SH; Tavakoli Pirzaman A; Barary M; Emamhadi M
Front Public Health; 2024; 12():1348015. PubMed ID: 38544731
[TBL] [Abstract][Full Text] [Related]
37. Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis.
Rotshild V; Hirsh-Raccah B; Miskin I; Muszkat M; Matok I
Sci Rep; 2021 Nov; 11(1):22777. PubMed ID: 34815503
[TBL] [Abstract][Full Text] [Related]
38. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
[TBL] [Abstract][Full Text] [Related]
39. Mild Facial Paresis in a Recipient of Gam-COVID-Vac Vaccine: A Case Report.
Mahmoudi Hamidabad N; Mafi AR; Abolmaali M
Clin Med Insights Case Rep; 2022; 15():11795476221129120. PubMed ID: 36225861
[TBL] [Abstract][Full Text] [Related]
40. Cancer or COVID-19? A Review of Recommendations for COVID-19 Vaccination in Cancer Patients.
Gundavda MK; Gundavda KK
Curr Treat Options Oncol; 2021 Sep; 22(10):95. PubMed ID: 34515857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
